DE3816534A1 - Verfahren zur herstellung von natuerlichem humanen interleukin-1(beta) (il-1(beta)) in zellkultur - Google Patents
Verfahren zur herstellung von natuerlichem humanen interleukin-1(beta) (il-1(beta)) in zellkulturInfo
- Publication number
- DE3816534A1 DE3816534A1 DE19883816534 DE3816534A DE3816534A1 DE 3816534 A1 DE3816534 A1 DE 3816534A1 DE 19883816534 DE19883816534 DE 19883816534 DE 3816534 A DE3816534 A DE 3816534A DE 3816534 A1 DE3816534 A1 DE 3816534A1
- Authority
- DE
- Germany
- Prior art keywords
- production
- cells
- gamma
- beta
- ifn
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 20
- 238000000034 method Methods 0.000 title claims abstract description 11
- 238000004113 cell culture Methods 0.000 title claims abstract description 9
- 101001033249 Homo sapiens Interleukin-1 beta Proteins 0.000 title claims abstract description 7
- 230000008569 process Effects 0.000 title claims abstract description 6
- 108090000193 Interleukin-1 beta Proteins 0.000 title abstract description 14
- 102000003777 Interleukin-1 beta Human genes 0.000 title abstract description 14
- 102000008070 Interferon-gamma Human genes 0.000 claims abstract description 13
- 108010074328 Interferon-gamma Proteins 0.000 claims abstract description 13
- 229940044627 gamma-interferon Drugs 0.000 claims abstract description 13
- 210000004881 tumor cell Anatomy 0.000 claims abstract description 3
- 210000004027 cell Anatomy 0.000 claims description 48
- 230000019189 interleukin-1 beta production Effects 0.000 claims description 6
- 230000004069 differentiation Effects 0.000 claims description 3
- 230000006698 induction Effects 0.000 claims description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 2
- 238000010923 batch production Methods 0.000 claims 1
- PHEDXBVPIONUQT-RGYGYFBISA-N phorbol 13-acetate 12-myristate Chemical compound C([C@]1(O)C(=O)C(C)=C[C@H]1[C@@]1(O)[C@H](C)[C@H]2OC(=O)CCCCCCCCCCCCC)C(CO)=C[C@H]1[C@H]1[C@]2(OC(C)=O)C1(C)C PHEDXBVPIONUQT-RGYGYFBISA-N 0.000 abstract description 4
- 102000000589 Interleukin-1 Human genes 0.000 description 9
- 108010002352 Interleukin-1 Proteins 0.000 description 9
- 238000012360 testing method Methods 0.000 description 8
- 239000001963 growth medium Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 102000000588 Interleukin-2 Human genes 0.000 description 4
- 108010002350 Interleukin-2 Proteins 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 102000015696 Interleukins Human genes 0.000 description 3
- 108010063738 Interleukins Proteins 0.000 description 3
- 210000001744 T-lymphocyte Anatomy 0.000 description 3
- 102100040247 Tumor necrosis factor Human genes 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229960003957 dexamethasone Drugs 0.000 description 3
- 229940047122 interleukins Drugs 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 238000003127 radioimmunoassay Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- VUDQSRFCCHQIIU-UHFFFAOYSA-N 1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl)hexan-1-one Chemical compound CCCCCC(=O)C1=C(O)C(Cl)=C(OC)C(Cl)=C1O VUDQSRFCCHQIIU-UHFFFAOYSA-N 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 101000942967 Homo sapiens Leukemia inhibitory factor Proteins 0.000 description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
- 229930182816 L-glutamine Natural products 0.000 description 2
- 102100032352 Leukemia inhibitory factor Human genes 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 239000012980 RPMI-1640 medium Substances 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 102000003390 tumor necrosis factor Human genes 0.000 description 2
- IQFYYKKMVGJFEH-OFKYTIFKSA-N 1-[(2r,4s,5r)-4-hydroxy-5-(tritiooxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound C1[C@H](O)[C@@H](CO[3H])O[C@H]1N1C(=O)NC(=O)C(C)=C1 IQFYYKKMVGJFEH-OFKYTIFKSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- HIYAVKIYRIFSCZ-CVXKHCKVSA-N Calcimycin Chemical compound CC([C@H]1OC2([C@@H](C[C@H]1C)C)O[C@H]([C@H](CC2)C)CC=1OC2=CC=C(C(=C2N=1)C(O)=O)NC)C(=O)C1=CC=CN1 HIYAVKIYRIFSCZ-CVXKHCKVSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 102000053187 Glucuronidase Human genes 0.000 description 1
- 108010060309 Glucuronidase Proteins 0.000 description 1
- 101000599940 Homo sapiens Interferon gamma Proteins 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- HIYAVKIYRIFSCZ-UHFFFAOYSA-N calcium ionophore A23187 Natural products N=1C2=C(C(O)=O)C(NC)=CC=C2OC=1CC(C(CC1)C)OC1(C(CC1C)C)OC1C(C)C(=O)C1=CC=CN1 HIYAVKIYRIFSCZ-UHFFFAOYSA-N 0.000 description 1
- 230000009260 cross reactivity Effects 0.000 description 1
- 238000005034 decoration Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 102000043557 human IFNG Human genes 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 239000000367 immunologic factor Substances 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004073 interleukin-2 production Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000002555 ionophore Substances 0.000 description 1
- 230000000236 ionophoric effect Effects 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000003003 monocyte-macrophage precursor cell Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000011533 pre-incubation Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- RZWIIPASKMUIAC-VQTJNVASSA-N thromboxane Chemical compound CCCCCCCC[C@H]1OCCC[C@@H]1CCCCCCC RZWIIPASKMUIAC-VQTJNVASSA-N 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000006433 tumor necrosis factor production Effects 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/545—IL-1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19883816534 DE3816534A1 (de) | 1988-05-14 | 1988-05-14 | Verfahren zur herstellung von natuerlichem humanen interleukin-1(beta) (il-1(beta)) in zellkultur |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19883816534 DE3816534A1 (de) | 1988-05-14 | 1988-05-14 | Verfahren zur herstellung von natuerlichem humanen interleukin-1(beta) (il-1(beta)) in zellkultur |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE3816534A1 true DE3816534A1 (de) | 1989-11-23 |
| DE3816534C2 DE3816534C2 (enExample) | 1990-02-15 |
Family
ID=6354400
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19883816534 Granted DE3816534A1 (de) | 1988-05-14 | 1988-05-14 | Verfahren zur herstellung von natuerlichem humanen interleukin-1(beta) (il-1(beta)) in zellkultur |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE3816534A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0710839A3 (en) * | 1994-11-01 | 1996-07-17 | Sumitomo Pharma | Method for measuring interferon activity |
-
1988
- 1988-05-14 DE DE19883816534 patent/DE3816534A1/de active Granted
Non-Patent Citations (1)
| Title |
|---|
| NICHTS ERMITTELT * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0710839A3 (en) * | 1994-11-01 | 1996-07-17 | Sumitomo Pharma | Method for measuring interferon activity |
| US5766864A (en) * | 1994-11-01 | 1998-06-16 | Sumitomo Pharmaceuticals Company, Ltd. | Method of measuring interferon acitivity |
Also Published As
| Publication number | Publication date |
|---|---|
| DE3816534C2 (enExample) | 1990-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2819094C2 (enExample) | ||
| DE69019640T2 (de) | Verfahren zur herstellung von beta-1,3-glucan in algen. | |
| DE3786794T2 (de) | Verahren zur vermehrung von knollen. | |
| David et al. | Distribution of interstitial cells and differentiating nematocytes in nests in Hydra attenuata | |
| EP0106179A1 (de) | Homogenes Human-Interleukin-2 und Verfahren zu seiner Herstellung | |
| DD250053A5 (de) | Verfahren zur herstellung einer synergistischen mischung von interferonen und tumor-nekrose-faktor | |
| DE159714T1 (de) | Herstellung von gamma-interferon. | |
| DE3034142C2 (enExample) | ||
| EP0513738A2 (de) | Serumfreies Medium zur Kultivierung von Säugerzellen | |
| DE2532779C3 (de) | Verfahren zum elektroquantitativen Bestimmen von Proteinen | |
| EP3330373A1 (de) | Verfahren zur kultivierung einer subpopulation zirkulierender epithelialer tumorzellen aus einer körperflüssigkeit | |
| DE3816534C2 (enExample) | ||
| DE69832662T2 (de) | Verfahren zur Kultur von Hepatocyten | |
| Eins et al. | GABA or sodium-bromide-induced plasticity of neurites of mouse neuroblastoma cells in culture: A quantitative study | |
| DE3319714C2 (enExample) | ||
| DE69009548T2 (de) | Neue Methode zur Induzierung der Ovulation beim Menschen. | |
| DE3434122C2 (enExample) | ||
| DE2817176C2 (de) | Verfahren zur Herstellung eines Filterstoffes mit großer spezifischer Oberfläche | |
| CH644271A5 (de) | Verfahren zur herstellung von fruehsommer-meningoenzephalitis-virus-vakzinen. | |
| DE2806515C2 (de) | Amorphes Heparin-Natrium und Verfahren zu dessen Herstellung | |
| DE3249215T1 (de) | Verfahren zur herstellung von humanem (gamma)-interferon | |
| DE731131C (de) | Gewinnung von Hefe | |
| AT392800B (de) | Verfahren zur erhoehung der ausbeute von cytokinen | |
| EP0135797A2 (de) | Verfahren zur Herstellung von Lymphotoxin und von Lymphotoxin-mRNA | |
| DE859194C (de) | Verfahren zur Zuechtung von Streptomycin erzeugenden Bakterienstaemmen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OP8 | Request for examination as to paragraph 44 patent law | ||
| D2 | Grant after examination | ||
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |